QuantRx Biomedical Corporation
QTXB
$0.0005
$0.0003150.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.30K | 26.90K | 3.60K | 6.60K | 8.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.30K | 26.90K | 3.60K | 6.60K | 8.50K |
| Operating Income | -7.30K | -26.90K | -3.60K | -6.60K | -8.50K |
| Income Before Tax | -61.20K | -80.80K | -57.50K | -61.00K | -63.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.20K | -80.80K | -57.50K | -61.00K | -63.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.20K | -80.80K | -57.50K | -61.00K | -63.00K |
| EBIT | -7.30K | -26.90K | -3.60K | -6.60K | -8.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 78.70M | 78.70M | 78.70M | 78.70M | 78.70M |
| Average Diluted Shares Outstanding | 78.70M | 78.70M | 78.70M | 78.70M | 78.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
